Lyssikatos Joseph P
SEC insider (Form 3/4/5 filer). CIK 0001967150. CHIEF SCIENTIFIC OFFICER at Enliven Therapeutics, Inc. (ELVN). 39 reported Form 4/5 transactions since Sep 2024; latest on Feb 12, 2026. Located in BOULDER, CO.
Companies Lyssikatos Joseph P has filed insider reports for
- Enliven Therapeutics, Inc. (ELVN): Officer, CHIEF SCIENTIFIC OFFICER
Lyssikatos Joseph P
CIK: 0001967150
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Enliven Therapeutics, Inc.
Discretionary Trading P&L
Holdings
Transaction History (39 total)
- Feb 12, 2026ELVN
Enliven Therapeutics, Inc.
AwardDirect18.8K shares- - Feb 6, 2026ELVN
Enliven Therapeutics, Inc.
SaleIndirect5K shares at avg. $29.04$145K - Jan 20, 2026ELVN
Enliven Therapeutics, Inc.
SaleIndirect5.5K shares at avg. $26.37$145K - Jan 20, 2026ELVN
Enliven Therapeutics, Inc.
SaleIndirect14.5K shares at avg. $26.90$390K - Jan 9, 2026ELVN
Enliven Therapeutics, Inc.
SaleIndirect41.2K shares at avg. $24.90$1.0M - Jan 9, 2026ELVN
Enliven Therapeutics, Inc.
SaleIndirect50K shares at avg. $29.13$1.5M - Jan 8, 2026ELVN
Enliven Therapeutics, Inc.
SaleIndirect33.8K shares at avg. $24.92$842K - Jan 8, 2026ELVN
Enliven Therapeutics, Inc.
SaleIndirect7.5K shares at avg. $20.13$151K - Dec 19, 2025ELVN
Enliven Therapeutics, Inc.
SaleIndirect5K shares at avg. $16.84$84K - Nov 19, 2025ELVN
Enliven Therapeutics, Inc.
SaleIndirect12K shares at avg. $22.30$268K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Feb 12, 2026 | ELVN Enliven Therapeutics, Inc. | Award | 18,750 | - | $0 | Direct |
| Feb 6, 2026 | ELVN Enliven Therapeutics, Inc. | Sale | 5,000 | $29.04 | $145,219 | Indirect |
| Jan 20, 2026 | ELVN Enliven Therapeutics, Inc. | Sale | 5,491 | $26.37 | $144,814 | Indirect |
| Jan 20, 2026 | ELVN Enliven Therapeutics, Inc. | Sale | 14,509 | $26.90 | $390,285 | Indirect |
| Jan 9, 2026 | ELVN Enliven Therapeutics, Inc. | Sale | 41,198 | $24.90 | $1,025,863 | Indirect |
| Jan 9, 2026 | ELVN Enliven Therapeutics, Inc. | Sale | 50,000 | $29.13 | $1,456,715 | Indirect |
| Jan 8, 2026 | ELVN Enliven Therapeutics, Inc. | Sale | 33,802 | $24.92 | $842,474 | Indirect |
| Jan 8, 2026 | ELVN Enliven Therapeutics, Inc. | Sale | 7,500 | $20.13 | $150,962 | Indirect |
| Dec 19, 2025 | ELVN Enliven Therapeutics, Inc. | Sale | 5,000 | $16.84 | $84,206 | Indirect |
| Nov 19, 2025 | ELVN Enliven Therapeutics, Inc. | Sale | 12,008 | $22.30 | $267,794 | Indirect |
1-10 of 39 transactions